{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:04:20Z","timestamp":1790071460365,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":9,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_11","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:17:32Z","timestamp":1790068652000},"page":"219-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR\/Cas9 Delivery Using Extracellular Vesicles"],"prefix":"10.1007","author":[{"given":"Peter","family":"Pe\u010dan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateja","family":"Man\u010dek-Keber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"15-16","key":"11_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1089\/hum.2024.258","volume":"36","author":"LL Dipalo","year":"2025","unstructured":"Dipalo LL, Mikkelsen JG, Gijsbers R et al. (2025) Trojan horse-like vehicles for CRISPR-Cas delivery: engineering extracellular vesicles and virus-like particles for precision gene editing in cystic fibrosis. Human Gene Ther 36(15-16):1021\u20131052","journal-title":"Human Gene Ther"},{"issue":"12","key":"11_CR2","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1021\/acssynbio.8b00192","volume":"7","author":"D Lain\u0161\u010dek","year":"2018","unstructured":"Lain\u0161\u010dek D, Kadunc L, Keber MM et al. (2018) Delivery of an artificial transcription regulator dCas9-VPR by extracellular vesicles for therapeutic gene activation. ACS Synth Biol 7(12):2715\u20132725","journal-title":"ACS Synth Biol"},{"issue":"38","key":"11_CR3","doi-asserted-by":"publisher","first-page":"e1902686","DOI":"10.1002\/smll.201902686","volume":"15","author":"R Chen","year":"2019","unstructured":"Chen R, Huang H, Liu H et al. (2019) Friend or Foe? Evidence indicates endogenous exosomes can deliver functional gRNA and Cas9 protein. Small (Weinheim an der Bergstrasse, Germany) 15(38):e1902686","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"1","key":"11_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymthe.2018.10.002","volume":"27","author":"LA Campbell","year":"2019","unstructured":"Campbell LA, Coke LM, Richie CT et al. (2019) Gesicle-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complex for inactivating the HIV provirus. Mol Ther 27(1):151\u2013163","journal-title":"Mol Ther"},{"issue":"6","key":"11_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.devcel.2020.11.007","volume":"55","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xu Q, Zi Z et al. (2020) Programmable extracellular vesicles for macromolecule delivery and genome modifications. Dev Cell 55(6):784\u2013801.e789","journal-title":"Dev Cell"},{"issue":"10","key":"11_CR6","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1039\/D0BM00427H","volume":"8","author":"Y Ye","year":"2020","unstructured":"Ye Y, Zhang X, Xie F et al. (2020) An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells. Biomater Sci 8(10):2966\u20132976","journal-title":"Biomater Sci"},{"issue":"4","key":"11_CR7","doi-asserted-by":"publisher","first-page":"e12196","DOI":"10.1002\/jev2.12196","volume":"11","author":"JA Whitley","year":"2022","unstructured":"Whitley JA, Kim S, Lou L et al. (2022) Encapsulating Cas9 into extracellular vesicles by protein myristoylation. J Extracell Vesicles 11(4):e12196","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"11_CR8","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","volume":"19","author":"P Kazemian","year":"2022","unstructured":"Kazemian P, Yu SY, Thomson SB et al. (2022) Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components. Mol Pharm 19(6):1669\u20131686","journal-title":"Mol Pharm"},{"issue":"1","key":"11_CR9","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E et al. (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750","journal-title":"J Extracell Vesicles"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:17:32Z","timestamp":1790068652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":9,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}